https://news.alfafinderusa.com/news/first-tracks-biotherapeutics-200-million-capital-raise-trax/ALFA USA Newsen2026-10-15T17:04:58-04:00First Tracks Biotherapeutics Secures $200 Million in Institutional Private Placementhttps://news.alfafinderusa.com/news/frazier-life-sciences-acquisition-corp-ii-78-million-ipo-biotech-spac/ALFA USA Newsen2026-10-15T16:49:58-04:00Frazier Life Sciences Acquisition Corp. II Prices $78 Million IPO to Target Biotech Sectorhttps://news.alfafinderusa.com/news/colony-bankcorp-shareholder-approval-first-reliance-merger-cban/ALFA USA Newsen2026-10-15T16:37:58-04:00Colony Bankcorp Shareholders Approve $163 Million Acquisition of First Reliancehttps://news.alfafinderusa.com/news/opko-health-labcorp-bioreference-divestiture-722-million/ALFA USA Newsen2026-10-15T16:23:28-04:00OPKO Health to Sell BioReference Testing Assets to Labcorp for $722 Millionhttps://news.alfafinderusa.com/news/consolidated-water-perc-pismo-beach-contract-win/ALFA USA Newsen2026-10-15T16:08:58-04:00Consolidated Water Secures $39.8 Million Contract for California Water Facilityhttps://news.alfafinderusa.com/news/greystone-logistics-q1-2026-results-revenue-decline/ALFA USA Newsen2026-10-15T13:33:26-04:00Greystone Logistics Revenue Halves to $5.32 Million in Q1 Following Major Customer Losshttps://news.alfafinderusa.com/news/alpha-digital-voltz-q1-2026-results/ALFA USA Newsen2026-10-15T10:07:00-04:00Alpha Digital Voltz Inc. Reports Q1-26 Net Loss of $0.37 Million Amid AI Pivothttps://news.alfafinderusa.com/news/quantum-si-regains-nasdaq-compliance-minimum-bid-price/ALFA USA Newsen2026-10-15T09:53:00-04:00Quantum-Si Regains Nasdaq Compliance After Stock Surges Over 90% in One Monthhttps://news.alfafinderusa.com/news/youlife-group-nasdaq-youl-h1-2026-financial-results/ALFA USA Newsen2026-10-15T09:38:00-04:00Youlife Group Inc. Reports H1 2026 Revenue Surge to $1.96 Billion Amid HR Acquisitionhttps://news.alfafinderusa.com/news/recursion-pharmaceuticals-200m-capital-raise-sanofi-milestone/ALFA USA Newsen2026-10-15T09:23:00-04:00Recursion Pharmaceuticals Shares Surge 15% After $200M Offering and $10M Sanofi Milestonehttps://news.alfafinderusa.com/news/pyrophyte-acquisition-corp-ii-sakuu-600-million-merger/ALFA USA Newsen2026-10-15T09:12:00-04:00Pyrophyte Acquisition Corp. II to Acquire Sakuu in $600 Million Tech Mergerhttps://news.alfafinderusa.com/news/dankon-corp-q2-2026-results/ALFA USA Newsen2026-10-15T08:58:00-04:00Dankon Corp Net Loss Narrows 29.4% in Q2 2026 Amid Revenue Declinehttps://news.alfafinderusa.com/news/asp-isotopes-necsa-haleu-joint-venture-south-africa-production/ALFA USA Newsen2026-10-15T08:45:00-04:00ASP Isotopes Shares Rise 6% After Forming 80/20 HALEU Production Joint Venture With Necsahttps://news.alfafinderusa.com/news/marsh-mclennan-q3-2026-results/ALFA USA Newsen2026-10-15T08:32:00-04:00Marsh & McLennan Reports $6,863 Million Revenue for Third Quarter 2026https://news.alfafinderusa.com/news/ccc-intelligent-solutions-acquired-gtcr-elliott-6-1-billion-deal/ALFA USA Newsen2026-10-15T08:19:00-04:00CCC Intelligent Solutions to be Acquired by GTCR and Elliott in $6.1 Billion Dealhttps://news.alfafinderusa.com/news/gibraltar-industries-divestiture-ds-brown-saint-gobain-208-million/ALFA USA Newsen2026-10-15T07:31:30-04:00Gibraltar Industries Shares Rise 6% After Selling Infrastructure Business for $208 Millionhttps://news.alfafinderusa.com/news/krystal-biotech-krys-kb113-gorlin-syndrome-clinical-data-regression-8-k/ALFA USA Newsen2026-10-15T07:14:30-04:00Krystal Biotech Reports 80% Lesion Regression in KB113 Gorlin Syndrome Pilot Studyhttps://news.alfafinderusa.com/news/penske-automotive-group-taken-private-16-billion-merger/ALFA USA Newsen2026-10-15T07:02:30-04:00Penske Automotive Shares Rise 8% After $16.3 Billion Merger to be Taken Privatehttps://news.alfafinderusa.com/news/venture-global-17-billion-power-expansion-ge-vernova-baker-hughes/ALFA USA Newsen2026-10-15T06:28:59-04:00Venture Global Secures $17.2 Billion Agreements for 10 GW Grid-Independent Power Expansionhttps://news.alfafinderusa.com/news/ocugen-ocu400-roots-pharmaceutical-licensing-deal-mena/ALFA USA Newsen2026-10-15T06:08:29-04:00Ocugen Secures $259 Million Licensing Deal for OCU400 Gene Therapy in MENA Regionhttps://news.alfafinderusa.com/news/watsco-granite-group-holdings-acquisition-505-million-deal/ALFA USA Newsen2026-10-14T16:10:37-04:00Watsco Finalizes $505 Million Acquisition of Granite Group Holdingshttps://news.alfafinderusa.com/news/mubadala-capital-completes-clear-channel-outdoor-acquisition-6-2-billion/ALFA USA Newsen2026-10-14T15:34:37-04:00Mubadala Capital Completes $6.2 Billion Acquisition of Clear Channel Outdoor Holdingshttps://news.alfafinderusa.com/news/ultragenyx-rare-divest-fda-priority-review-voucher-203-million/ALFA USA Newsen2026-10-14T10:31:35-04:00Ultragenyx (RARE) to Divest FDA Priority Review Voucher for $203 Million in Cashhttps://news.alfafinderusa.com/news/skyx-platforms-completes-deako-acquisition-ma-deal/ALFA USA Newsen2026-10-14T10:18:05-04:00SKYX Platforms Completes Deako, Inc. Acquisition in $12.5 Million Cash and Note Dealhttps://news.alfafinderusa.com/news/sono-tek-corp-q2-2026-results/ALFA USA Newsen2026-10-14T10:04:04-04:00Sono-Tek Corp Reports Q2 Revenue Growth to $5.23 Million Despite Net Income Diphttps://news.alfafinderusa.com/news/pulse-biosciences-clayman-thyroid-partnership-npulse-vybrance/ALFA USA Newsen2026-10-14T09:52:34-04:00Pulse Biosciences Partners With Clayman Thyroid Center for nPulse Vybrance Deploymenthttps://news.alfafinderusa.com/news/vir-biotechnology-gilead-sciences-oncology-collaboration-t-cell-engagers/ALFA USA Newsen2026-10-14T09:38:04-04:00Vir Biotechnology Signs $1.875 Billion Gilead Oncology Collaborationhttps://news.alfafinderusa.com/news/cytodyn-inc-q1-2026-results-net-loss/ALFA USA Newsen2026-10-14T09:24:34-04:00CytoDyn Reports Q1 2026 Net Loss of $19.9 Million Amid Debt Extinguishmenthttps://news.alfafinderusa.com/news/flex-completes-1-1-billion-epc-power-acquisition-ai-infrastructure/ALFA USA Newsen2026-10-14T09:12:34-04:00Flex Ltd. Completes $1.1 Billion EPC Power Acquisition to Scale AI Infrastructurehttps://news.alfafinderusa.com/news/jingbo-technology-q2-2026-results/ALFA USA Newsen2026-10-14T09:00:34-04:00Jingbo Technology Narrowed Net Loss to $0.51 Million in Q2 2026 Despite Revenue Diphttps://news.alfafinderusa.com/news/profound-medical-tulsa-pro-clinical-data-imri-symposium-2026/ALFA USA Newsen2026-10-14T08:48:34-04:00Profound Medical Data Shows TULSA-PRO Superiority in Erectile Function Preservationhttps://news.alfafinderusa.com/news/fermi-frmi-tensorwave-contract-win-6-5-billion/ALFA USA Newsen2026-10-14T08:38:04-04:00Fermi Inc. Secures $6.5 Billion Turnkey Lease Agreement with TensorWavehttps://news.alfafinderusa.com/news/strive-asst-369-million-warrant-exercise-bitcoin-purchase/ALFA USA Newsen2026-10-14T08:23:04-04:00Strive, Inc. Generates $369.2 Million from Warrants to Expand Bitcoin Treasuryhttps://news.alfafinderusa.com/news/ankam-inc-q3-2026-results/ALFA USA Newsen2026-10-14T08:10:04-04:00Ankam, Inc. Q3 2026 Results: Net Loss Widens to $0.11 Million on Zero Revenuehttps://news.alfafinderusa.com/news/entrada-therapeutics-trda-dmd-clinical-trial-results-elevate-45-201/ALFA USA Newsen2026-10-14T07:57:04-04:00Entrada Therapeutics Reports Positive Topline Data for DMD Treatment ENTR-601-45https://news.alfafinderusa.com/news/aquestive-therapeutics-eton-pharmaceuticals-licensing-deal-libervant/ALFA USA Newsen2026-10-14T07:30:34-04:00Aquestive Therapeutics Secures $57.5 Million Licensing Deal with Eton Pharmaceuticalshttps://news.alfafinderusa.com/news/eton-pharmaceuticals-libervant-licensing-deal-aquestive-therapeutics/ALFA USA Newsen2026-10-14T07:18:04-04:00Eton Pharmaceuticals Shares Rise 5% After Securing U.S. Rights to LIBERVANThttps://news.alfafinderusa.com/news/fortunex-acquisition-fxac-wt-realty-merger-valuation-amendment/ALFA USA Newsen2026-10-14T06:27:34-04:00FortuneX Acquisition FXAC Amends WT Realty Merger Terms to $525 Million Valuehttps://news.alfafinderusa.com/news/integral-technologies-inc-fy-2026-financial-results/ALFA USA Newsen2026-10-14T06:16:04-04:00Integral Technologies Inc Reports $0.78 Million Net Loss for Fiscal 2026https://news.alfafinderusa.com/news/pioneer-acquisition-corp-green-ai-cloud-merger-300-million/ALFA USA Newsen2026-10-14T06:02:04-04:00Pioneer Acquisition I Corp to Merge with Green AI Cloud in $300 Million SPAC Deal